ARNI treatment in HFpEF shows benefit in secondary outcomes, but misses significance in primary endpoint
Prof. Scott Solomon is Senior Physician at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School, both in Boston, MA, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: